Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer

S. Zhong, C. R. Fields, N. Su, Y. X. Pan, K. D. Robertson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences